GlobeNewsWire · VCYT · October 23, 2026

Phase III Trial Shows Veracyte's Decipher Prostate Test Can Predict Benefit from Adding Abiraterone to Treatment in Very High-Risk Prostate Cancer

Get the app for more

Explore stock news, insights and company research.